Newsbot

Blue Owl Founders Pledged $1.9 Billion Stake Before Stock Plunge

Blue Owl Capital Inc.’s record-setting stock plunge was triggered by doubts about the firm’s private credit investments. Now, a different form of leverage is threatening to bring more instability to the shares: its founders’ loans.

Country to ban all U.S. airlines from refueling stops

Following the U.S. operation that led to the removal of Venezuelan leader Nicolás Maduro at the start of January, President Donald Trump has made repeated threats on the Caribbean island nation of Cuba. After calling the country "an unusual and extraordinary threat" to U.S. national security, the ...

Bank of America resets Uber stock price after earnings

Uber Technologies posted a strong fourth quarter, but stock pullbacks show that investors are focused on what lies ahead. Analysts are not entirely optimistic about its near-term profitability, as they are concerned about margin compression.  At least one bank thinks investors need to brace ...

Kaiserslautern: ACC will kein Batteriezellwerk mehr bauen

Erst Northvolt, dann Cellforce und nun ACC: Trotz Elektrowende in der Automobilindustrie endet ein weiteres prominentes Batteriezellprojekt. Obwohl Projekt und Standort zuvor mit Hunderten Millionen Euro gefördert wurden.

Stellantis Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Stellantis nach milliardenschweren Abschreibungen auf die Elektroauto-Strategie von 13 auf 8 Euro gesenkt, aber die Einstufung auf "Kaufen" belassen. Die seien überraschend hoch, ...

TOP-5-Kursziele der Analysten am 09.02.26

Grenke AG [DE000A161N30] Berenberg nimmt die Aktien neu in die Favoritenliste auf - Kursziel 29 Euro (95 % Kurspotenzial) Nach Einschätzung von Analyst Marius Fuhrberg dürfte die anstehende Jahresbilanz...

Raízen Hiring Advisers as Bonds Slump on Debt Concerns

Raízen SA’s credit rating was slashed deeply into junk from investment grade by Fitch Ratings and S&P Global Ratings as the Brazilian sugar-and-ethanol company faces a growing cash crunch, extending a selloff in its bonds that’s cut the prices nearly in half over the past week.

Assessing Hims & Hers Health (HIMS) Valuation After Compounded GLP-1 Launch And Rapid Regulatory Retreat

Hims & Hers Health (HIMS) has been at the center of attention after launching a discounted compounded semaglutide weight loss pill, then quickly withdrawing it following legal threats from Novo Nordisk and heightened FDA enforcement signals. See our latest analysis for Hims & Hers Health. The regulatory backlash around compounded GLP-1 drugs has hit sentiment hard, with a 30-day share price return of 27.36% and a year to date share price return of 31.10% pointing to fading momentum despite a...

Novo Sues Hims Over Compounded Version of Oral Wegovy Pill

Novo Nordisk has sued Hims for allegedly violating patents protecting semaglutide, seeking potentially “hundreds of millions” in damages, John Kuckelman, the pharma’s general counsel, said. The wellness platform pulled its version of the drug just days after launching it.

Shell (ex Royal Dutch Shell) Sector Perform

NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Shell nach einer Investorenveranstaltung zu den Quartalszahlen mit einem Kursziel von 3200 Pence auf "Sector Perform" belassen. Der Ölkonzern habe zwar Fortschritte bei den Kosten ...

Spencer Jakab | Stock-Investing Lessons From the TV

Markets are motivated by a mixture of fear and greed. You could say the same about many game shows. In the latest edition of my Markets A.M. newsletter, I consider “Deal or No Deal”—and what it tells us about why most people struggle to just match the market’s return. You can [sign up for the newsle